HLA
DRNA

Hamilton Lane Advisors’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Hamilton Lane Advisors’s Portfolio DRNA Stock Details DRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-17,462
Closed -$447K – 97
2021
Q1 		$447K Sell
17,462
-12,443
-42% -$319K 0.15% 57
2020
Q4 		$659K Buy
29,905
+16,329
+120% +$360K 0.25% 41
2020
Q3 		$244K Buy
+13,576
New +$244K 0.12% 43